Winship Cancer Institute - Emory University
Seeing over 17,000 patients a year, Winship Cancer Institute of Emory University is Georgia's only National Cancer Institute-designated comprehensive cancer center and serves as the coordinating center for cancer research, education and care throughout Emory University.
Immunotherapy Trials for Nasopharyngeal Cancers
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Nabil Saba
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Nabil Saba
Disclaimer: This video was recorded prior to the FDA approval on October 27, 2023, of toripalimab-tpzi with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent, locally advanced NPC. FDA also approved toripalimab-tpzi as a single agent for adults with recurrent unresectable or metastatic NPC with disease progression on or after a platinum-containing chemotherapy.
Login to view comments.
Click here to Login
